Cτ for lin and lin-up/log-down [NCA / SHAM]

posted by Astea – Russia, 2019-02-10 21:50 (2294 d 02:06 ago) – Posting: # 19898
Views: 14,356

Dear Helmut!

I'm grateful for your quick reply!

❝ By the linear trapezoidal method (dammit!)… With lin-up/log-down I get 1298.


For some reason (may be for it's simplicity) russians like linear method and include it into the protocols.

I recalculated via lin-up/log-down and now I'm puzzled with a new question: why do Cτ's differ by the way of calculation AUC? For linear I've got 3,38... (by the way, what are (1) and (2) on your presentation, slide 18?)

❝ Let’s call the first two datapoints t0|C0...


Is it correct to use t0 and t1, if dosing time happened between this two points? I mean for the time before dose (t0), the curve should be decreasing exponentially, while for the t1 it should be rising similar to linear?

❝ ❝ What is the best way to handle with BLQ in the end of the dosing period for steady-state?

❝ Lin-up/log-down as usual. Don’t you have any accumulation or is the method lousy? ;-)


I was lucky enough not to get it till now but shit happens, you know, and a danger foreseen is half avoided. Is it a bad idea to miss that BLQ for ss elimination part?

What is about regulatory's acceptance of any of the calculation modifications? I may use profound methods of numeric integration, but would it be accepted?

"Being in minority, even a minority of one, did not make you mad"

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,683 registered users;
46 visitors (0 registered, 46 guests [including 28 identified bots]).
Forum time: 00:56 CEST (Europe/Vienna)

Pharmacokinetics may be simply defined as
what the body does to the drug,
as opposed to pharmacodynamics, which may be defined as
what the drug does to the body.    Leslie Z. Benet

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5